Get the Stockscreener App
0.86
1.96%
-0.0139
Oragenics Inc stock is traded at $0.86, with a volume of 4,742.
It is down -1.96% in the last 24 hours and down -3.02% over the past month.
Oragenics, Inc. focuses on developing antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients. Its product candidates also comprise LPT3-04, a naturally occurring dietary substance for weight loss; and SMaRT Replacement Therapy, a topical treatment applied to the teeth to protect against tooth decay. Oragenics, Inc. has collaboration agreements with Intrexon Corporation and its subsidiary, Intrexon Actobiotics NV to develop AG013 as a potential treatment of oral mucositis for cancer patients. It also has license agreements with LPThera LLC to develop LPT3-04, a weight-loss product candidate; and Texas A&M University System for access to new homologs of the lantibiotic Mutacin 1140 (MU1140) and other lantibiotics, as well as holds licenses from the University of Florida Research Foundation, Inc. for MU1140 product candidates. The company was formerly known as Oragen, Inc. Oragenics, Inc. was founded in 1996 and is headquartered in Tampa, Florida.
See More
Previous Close:
$0.8739
Open:
$0.8702
24h Volume:
4,742
Relative Volume:
0.04
Market Cap:
$3.57M
Revenue:
-
Net Income/Loss:
$-20.26M
P/E Ratio:
-0.1007
EPS:
-8.54
Net Cash Flow:
$-8.25M
1W Performance:
+13.57%
1M Performance:
-3.02%
6M Performance:
-44.00%
1Y Performance:
-93.03%
1-Day Range:
$0.8568
$0.8999
1-Week Range:
$0.735
$0.8999
52-Week Range:
$0.735
$18.90
Oragenics Inc Stock (OGEN) Company Profile
Name
Oragenics Inc
Sector
Industry
Phone
813-286-7900
Address
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Compare OGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
0.8568 | 3.64M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.70 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.49 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
393.09 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.04 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.03 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oragenics Inc Stock (OGEN) Latest News
Is Oragenics Inc. stock vulnerable to rate hikesStock Market Trends & Outstanding Investment Returns - bollywoodhelpline.com
Certain Warrants of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Common Stock of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Convertible Preferred Stock. of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Outlook & High Return Stock Watch Alerts - Улправда
Aug Patterns: Why analysts upgrade Oragenics Inc. stockDollar Strength & Weekly Market Pulse Updates - Улправда
Growth Review: Can Oragenics Inc. stock beat market expectations this quarterJuly 2025 Trends & Free Community Consensus Stock Picks - moha.gov.vn
Why analysts upgrade Oragenics Inc. stockJuly 2025 Closing Moves & Long-Term Growth Plans - Улправда
Momentum Shift: Is Oragenics Inc. stock resilient to inflationJuly 2025 Market Mood & Fast Gain Stock Tips - Улправда
Will Oragenics Inc. stock deliver shareholder valueWeekly Profit Report & High Return Trade Opportunity Guides - Улправда
Is Oragenics Inc. stock resilient to inflationJuly 2025 Summary & Verified Short-Term Plans - Улправда
Can Oragenics Inc. stock sustain revenue growthWeekly Market Report & Weekly Chart Analysis and Guides - DonanımHaber
Can Oragenics Inc. stock beat market expectations this quarterJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - DonanımHaber
Will Oragenics Inc. stock reach all time highs in 2025Market Growth Summary & Daily Volume Surge Trade Alerts - Улправда
Is Oragenics Inc. stock trading at a premium valuationJuly 2025 Levels & Weekly High Potential Stock Alerts - Улправда
Aug Reactions: Is Oragenics Inc. stock trading at a premium valuationWeekly Trend Summary & Daily Chart Pattern Signal Reports - Улправда
Nasdaq Moves: Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Volume & Verified Technical Signals - Улправда
Earnings Miss: Will Oragenics Inc. stock reach all time highs in 2025 - Улправда
Oragenics (OGEN) CEO/CFO receives 250,000 stock options at $0.93 - Stock Titan
Oragenics (OGEN) reports immediate-vesting stock option grants to director - Stock Titan
Oragenics Adjusts Executive Compensation Plan - TipRanks
[Form 4] ORAGENICS INC Insider Trading Activity - Stock Titan
Oragenics (OGEN) discloses 125,000 director stock options grant - Stock Titan
Oragenics (OGEN) director granted 125,000 options at $0.93 exercise price - Stock Titan
Oragenics (OGEN) Awards Director 125,000 Stock Options at $0.93 Exercise Price - Stock Titan
Dir Telling Files To Sell 210 Of Oragenics Inc [OGEN] - TradingView — Track All Markets
OGEN (OGEN) holder files Form 144 to sell 210 common shares - Stock Titan
Oragenics (NYSEAMERICAN:OGEN) Shares Down 1.5% – What’s Next? - Defense World
Why Oragenics Inc. stock attracts wealthy investorsAnalyst Upgrade & Consistent Profit Focused Trading Strategies - Newser
Will Oragenics Inc. stock benefit from infrastructure billJuly 2025 Market Mood & Weekly Momentum Picks - Newser
Is Oragenics Inc. stock attractive post correctionJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
Why Oragenics Inc. stock is a strong buy callJuly 2025 Review & Accurate Intraday Trade Tips - Newser
Downgrade Watch: Can Oragenics Inc stock deliver 10 annual returnsQuarterly Trade Summary & Daily Profit Focused Stock Screening - BỘ NỘI VỤ
Can Oragenics Inc. stock hit record highs againWeekly Stock Analysis & Smart Investment Allocation Insights - Newser
Will Oragenics Inc. stock hit Wall Street targets2025 Top Gainers & Short-Term Trading Opportunity Alerts - BỘ NỘI VỤ
Oragenics Inc. (OGEN) 5.26% in After-hours: What’s Driving the Move? - Stocks Telegraph
Preferred dividends of Oragenics, Inc. – MUN:UAV0 - TradingView
Can Oragenics Inc. stock resist broad market declinesQuarterly Profit Report & AI Optimized Trade Strategies - newser.com
Will Oragenics Inc. stock see valuation expansionMarket Performance Recap & Stock Timing and Entry Methods - newser.com
How Oragenics Inc. stock performs in interest rate cycles2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Combining machine learning predictions for Oragenics Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - newser.com
Will Oragenics Inc. stock benefit from infrastructure spendingQuarterly Profit Summary & Fast Momentum Entry Tips - newser.com
Will Oragenics Inc. stock maintain momentum in 2025Weekly Trade Report & Verified Chart Pattern Signals - newser.com
Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN
What technical charts say about Oragenics Inc. stock2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Oragenics Inc. stock outlook for YEARQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Oragenics Inc Stock (OGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.60%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):